EUVIMEDEUVIMED entdecken
Open Access

Variability in Urinary Nicotine Exposure Biomarker Levels Between Waves 1 (2013–2014) and 2 (2014–2015) in the Population Assessment of Tobacco and Health Study

David L Ashley iD, Wanzhe Zhu, Lanqing Wang iD, Connie Sosnoff iD, Jun Feng, Arseima Y Del Valle-Pinero, Yu-Ching Cheng, Cindy M Chang, Dana van Bemmel, Nicolette Borek, Heather L Kimmel iD, Marushka L Silveira iD und 1 weitere

Nicotine & Tobacco Research · 22.03.2023 · 25 (4) · 616-623

DOI: 10.1093/ntr/ntac056 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nicotine & Tobacco Research, online erschienen am 25.03.2022. Verfasst von David L Ashley und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Population Health Sciences, School of Public Health, Georgia State University, Atlanta, GA, USA. Hauptthemen laut MEDLINE: Nicotine, Tobacco Products. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDA NIH HHS, NIH HHS, FDA HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

To date, no studies have evaluated the consistency of biomarker levels in people who smoke over a long-time period in real-world conditions with a large number of subjects and included use behavior and measures of nicotine metabolism. We evaluated the variability of biomarkers of nicotine exposure over approximately a 1-year period in people who exclusively smoke cigarettes, including intensity and recency of use and brand switching to assess impact on understanding associations with product characteristics. Aims and Methods Multivariate regression analysis of longitudinal repeated measures of urinary biomarkers of nicotine exposure from 916 adults in the Population Assessment of Tobacco and Health (PATH) Study with demographic characteristics and use behavior variables. Intraclass correlation coefficients (ICCs) were calculated to examine individual variation of nicotine biomarkers and the uncertainty of repeat measures at two time points (Waves 1 and 2).

Results

Age, race, and urinary creatinine were significant covariates of urinary cotinine. When including use behavior, recency, and intensity of use were highly significant and variance decreased to a higher extent between than within subjects. The ICC for urinary cotinine decreased from 0.7530 with no use behavior variables in the model to 0.5763 when included. Similar results were found for total nicotine equivalents.

Conclusions

Urinary nicotine biomarkers in the PATH Study showed good consistency between Waves 1 and 2. Use behavior measures such as time since last smoked a cigarette and number of cigarettes smoked in the past 30 days are important to include when assessing factors that may influence biomarker concentrations.

Implications

The results of this study show that the consistency of the nicotine biomarkers cotinine and total nicotine equivalents in spot urine samples from Waves 1 to 2 of the PATH Study is high enough that these data are useful to evaluate the association of cigarette characteristics with biomarkers of exposure under real-world use conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NicotineTobacco ProductsAdultHumansCotinineBiomarkers

Substanzen

NicotineCotinineBiomarkers

Autor:innen und Institutionen

  • Department of Population Health Sciences, School of Public Health, Georgia State University, Atlanta, GA, USA.
  • Division of Laboratory Sciences, National Center for Environmental Health, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Office of Science, Center for Tobacco Products, U.S. Food and Drug Administration, Silver Spring, MD, USA.
  • Division of Epidemiology, Services and Prevention Research, National Institute for Drug Abuse, National Institutes of Health, Bethesda, MD, USA.
  • Kelly Government Solutions, Rockville, MD, USA.

ORCID-Profile: David L Ashley, Lanqing Wang, Connie Sosnoff, Heather L Kimmel, Marushka L Silveira

Förderung

  • NIDA NIH HHS
  • NIH HHS
  • FDA HHS
  • National Institute on Drug Abuse
  • National Institutes of Health
  • Center for Tobacco Products
  • Food and Drug Administration
  • Department of Health and Human Services

Zitieren

APA

Ashley, D. L., Zhu, W., Wang, L., Sosnoff, C., Feng, J., Del Valle-Pinero, A. Y., Cheng, Y. C., Chang, C. M., van Bemmel, D., Borek, N., Kimmel, H. L., Silveira, M. L., & Blount, B. C. (2023). Variability in Urinary Nicotine Exposure Biomarker Levels Between Waves 1 (2013–2014) and 2 (2014–2015) in the Population Assessment of Tobacco and Health Study. Nicotine & Tobacco Research, 25(4), 616-623. https://doi.org/10.1093/ntr/ntac056

Vancouver

Ashley DL, Zhu W, Wang L, Sosnoff C, Feng J, Del Valle-Pinero AY, et al. Variability in Urinary Nicotine Exposure Biomarker Levels Between Waves 1 (2013–2014) and 2 (2014–2015) in the Population Assessment of Tobacco and Health Study. Nicotine & Tobacco Research. 2023;25(4):616-623. doi:10.1093/ntr/ntac056

BibTeX
@article{Ashley2023,
  author = {Ashley, David L and Zhu, Wanzhe and Wang, Lanqing and Sosnoff, Connie and Feng, Jun and Del Valle-Pinero, Arseima Y and Cheng, Yu-Ching and Chang, Cindy M and van Bemmel, Dana and Borek, Nicolette and Kimmel, Heather L and Silveira, Marushka L and Blount, Benjamin C},
  title = {Variability in Urinary Nicotine Exposure Biomarker Levels Between Waves 1 (2013–2014) and 2 (2014–2015) in the Population Assessment of Tobacco and Health Study},
  journal = {Nicotine & Tobacco Research},
  year = {2023},
  volume = {25},
  number = {4},
  pages = {616--623},
  doi = {10.1093/ntr/ntac056}
}
Kostenlos starten →